Cargando…
Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling
Aberrant expression of lymphoid enhancer-binding factor-1 (LEF1) has been identified in various hematological malignancies including multiple myeloma (MM). However, the exact role of LEF1 in MM remains largely unknown. Here, we showed that knockdown of LEF1 could apparently impair the proliferation,...
Autores principales: | Zhang, Guihua, Miao, Faan, Liu, Kaige, Wu, Jinyan, Xu, Jinge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287265/ https://www.ncbi.nlm.nih.gov/pubmed/34269120 http://dx.doi.org/10.1177/15330338211034270 |
Ejemplares similares
-
Mesenchymal stem cells from bone marrow regulate invasion and drug resistance of multiple myeloma cells by secreting chemokine CXCL13
por: Zhang, Guihua, et al.
Publicado: (2020) -
Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
por: Byun, Jae Yong, et al.
Publicado: (2010) -
Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB Activation
por: Nagabhushana, Ananthamurthy, et al.
Publicado: (2011) -
Downregulation of miR-181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF-κB signaling pathway
por: Yang, Xifeng, et al.
Publicado: (2020) -
Downregulation of m(6)A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway
por: Wang, Jin, et al.
Publicado: (2021)